Melittin (12-26)[A4L]-AGP-Thanatin

General Information


DRACP ID  DRACP03776

Peptide Name   Melittin (12-26)[A4L]-AGP-Thanatin

Sequence  GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM

Sequence Length  39

UniProt ID  P55788 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C198H338N64O48S3

Absent amino acids  DEFH

Common amino acids  KR

Mass  515742

Pl  12.04

Basic residues  10

Acidic residues  0

Hydrophobic residues  10

Net charge  10

Boman Index  -8383

Hydrophobicity  -67.18

Aliphatic Index  80

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  7115

Absorbance 280nm  187.24

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30701481

Title  Design and activity study of a melittin-thanatin hybrid peptide

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12528

DRACP is developed by Dr.Zheng's team.